James, S., Armstrong, P., Califf, R., Husted, S., Kontny, F., Niemminen, M., ...
AIMS: The safety and efficacy of abciximab in addition to low-molecular-weight-heparin as the primary medical treatment of acute coronary syndromes has not previously been investigated. METHODS AND...
James, S., Armstrong, P., Califf, R., Husted, S., Kontny, F., Niemminen, M., ...
Aims The safety and efficacy of abciximab in addition to low-molecular-weight-heparin as the primary medical treatment of acute coronary syndromes has not previously been investigated. Methods and...
Husted, S.E., Wallentin, L., Lagerqvist, B., Kontny, F., Ståhle, E., Swahn, E.
Aims The FRISC II trial demonstrated that, for patients with unstable coronary artery disease, an early invasive strategy following acute treatment with dalteparin and aspirin, was superior to a more...
Fibrin monomer antigen; a novel marker of mortality in acute myocardial infarction (1999)
Kontny, F., Dempfle, C.E., Abildgaard, U.
Aims A novel sensitive method for analyses of soluble fibrin monomer antigen was used to assess the predictive value of fibrin monomer when estimating mortality after acute myocardial infarction....
KONTNY, F., DALE, J., ABILDGAARD, U., HEGRENAES, L., LEM, P., MORSTØL, T.
In a prospective non-randomized study, 229 patients with a verfied first acute anterior myocardial infarction (AAMI) underwent echocardiography before discharge in order to study left ventricular...
KONTNY, F., DALE, J., HEGRENÆS, L., LEM, P., SØBERG, T., MORSTØL, T.
The prevalence of left ventricular (LV) thrombosis and incidence of arterial embolism after acute anterior myocardial infarction (AAMI) treated with streptokinase 1.5 × 106 IU intravenously was...
Lagerqvist, B, Diderholm, E, Lindahl, B, Husted, S, Kontny, F, Ståhle, E, ...
Objective: To develop a scoring system for risk stratification and evaluation of the effect of an early invasive strategy for treatment of unstable coronary artery disease (CAD).